Quick Comparison
| Argireline (Acetyl Hexapeptide-3) | Vitamin K | |
|---|---|---|
| Typical Concentration | Typically used at 5-10% concentration. Apply twice daily to expression line areas (forehead, around eyes, between brows). Effects visible after 2-4 weeks. Must be used continuously — effects reverse when stopped. | Concentrations: 1-5% in eye creams and targeted treatments. Apply to under-eye area and areas with visible blood vessels. Results take 4-8 weeks of consistent use. Phytonadione (vitamin K1) is the most common topical form. |
| Application | Topical (serum, cream). Water-soluble. Apply directly to expression line areas. | Topical (eye cream, serum). Apply gently to under-eye area and areas of concern. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Argireline (Acetyl Hexapeptide-3)
Argireline (acetyl hexapeptide-3) mimics the C-terminal region of SNAP-25, a core SNARE complex component. The SNARE complex (SNAP-25, syntaxin, synaptobrevin) mediates vesicle fusion at the neuromuscular junction for acetylcholine release. Argireline competes with SNAP-25 for syntaxin binding, partially disrupting SNARE assembly and reducing neurotransmitter exocytosis. This decreases acetylcholine release and attenuates facial muscle contraction intensity. The effect is dose-dependent, localized, and reversible—unlike botulinum toxin's enzymatic cleavage of SNAP-25. Clinical studies show ~30% wrinkle reduction versus 80%+ with injectable neurotoxins. Provides non-invasive expression line softening.
Vitamin K
Vitamin K (phytonadione/K1) is cofactor for gamma-glutamyl carboxylase, which carboxylates glutamic acid residues in clotting factors II, VII, IX, X and proteins S, C — essential for calcium binding and coagulation cascade activation. Topically promotes reabsorption of subcutaneous extravasated blood by activating local clotting cascades that convert leaked hemoglobin to biliverdin and bilirubin for clearance. Strengthens capillary walls, reduces vascular permeability. For vascular dark circles: improves vessel wall integrity, reduces hemosiderin deposition. Supports elastic fiber production through matrix Gla protein carboxylation. Has anti-inflammatory effects. Clinical use: bruising, post-procedure ecchymosis, periorbital vascular hyperpigmentation. Results require 4-8 weeks consistent application.
Risks & Safety
Argireline (Acetyl Hexapeptide-3)
Common
Very well-tolerated. Occasional mild tingling.
Serious
None documented.
Rare
Allergic reaction. At very high concentrations, some users report a slight 'droopy' feeling in the treated area.
Vitamin K
Common
Essentially none — very well-tolerated.
Serious
None documented topically.
Rare
Allergic contact dermatitis.
Full Profiles
Argireline (Acetyl Hexapeptide-3) →
Known as 'topical Botox,' Argireline is a peptide that reduces the appearance of expression lines by partially inhibiting the SNARE complex — the same mechanism targeted by botulinum toxin, but through topical application rather than injection. The effect is much milder than Botox (roughly 30% wrinkle reduction vs 80%+) but provides a non-invasive option for forehead lines, crow's feet, and frown lines.
Vitamin K →
A fat-soluble vitamin that supports blood clotting and blood vessel integrity. In skincare, vitamin K is primarily used for dark circles under the eyes (caused by visible blood vessels), bruising, spider veins, and post-procedure redness. It strengthens capillary walls and supports the reabsorption of blood that has leaked from damaged vessels. Often combined with retinol and vitamin C in eye creams.